The KidneyIntelX platform utilizes plasma levels of KIM-1, soluble tumor necrosis factor (sTNF) receptor-1, and sTNF receptor-2 to predict diabetic kidney disease progression over 5 years [130] A biomarker panel comprising serum creatinine, osteopontin, tryptase, urea, and estimated glomerular filtration rate (eGFR) achieved an 84.3% accuracy in predicting CKD progression [131] Combining standard markers such as creatinine and cystatin C with sensitive biomarkers such as beta-trace protein (BTP), tissue inhibitor of metalloproteinase-1, TGF-, asymmetric dimethylarginine (ADMA), TNF-, and N-terminal pro-B-type natriuretic peptide (proBNP) have shown improved diagnostic performance for early CKD detection [132] Panels integrating tumor necrosis factor receptor (TNFR)-1, TNFR-2, and KIM-1 have demonstrated superior predictive accuracy for renal function decline The kidney injury test uses urinary markers including cell-free DNA (cfDNA), methylated cfDNA, clusterin, C-X-C motif chemokine ligand 10 (CXCL10), total protein, and creatinine to generate a diagnostic score with high sensitivity and specificity, even when eGFR and proteinuria remain within normal ranges For AKI detection, urinary biomarker panels combining NGAL, KIM-1, cystatin C, and hemojuvelin have shown strong predictive value
As aging progresses, the accumulation of lipid peroxides increases, causing instability in cell membranes, particularly in muscle cells
Studies show that IGF-1 plays a crucial role in cell growth, differentiation, and regeneration, making it a key component in muscle development, metabolic health, and neuroprotection
Gut Research: The mix of BPC-157 and KPV makes GKP BLEND very valuable for gut research
